ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).Clin Microbiol Infect. 2018 Feb 12. pii: S1198-743X(18)30150-2. [Epub ahead of print] Review. F.I.: 5.292

Inicio Repositorio ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).Clin Microbiol Infect. 2018 Feb 12. pii: S1198-743X(18)30150-2. [Epub ahead of print] Review. F.I.: 5.292

2018/01

Autores/as:

Winthrop KL, Mariette X, Silva JT, Benamu E, Calabrese LH, Dumusc A, Smolen JS, Aguado JM, Fernández-Ruiz M.

Servicio:

Enfermedades Infecciosas. Complejo Hospitalario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen PubMed»,»link»:»Winthrop KL, Mariette X, Silva JT, Benamu E, Calabrese LH, Dumusc A, Smolen JS, Aguado JM, Fernu00e1ndez-Ruiz M.»}

info@areasaludbadajoz.com

Contacto

Salud

Información

Ciudadanos

info@areasaludbadajoz.com

Contacto

Salud​

Información​

Ciudadanos​

Salud

Información

Ciudadanos